The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidence of pneumonitis with use of PD-1 and PD-L1 inhibitors in non-small cell lung cancer: A systematic review and meta-analysis of trials.
 
Monica Khunger
No Relationships to Disclose
 
Vinay Pasupuleti
No Relationships to Disclose
 
Sagar Rakshit
No Relationships to Disclose
 
Prantesh Jain
No Relationships to Disclose
 
Peter J. Mazzone
Consulting or Advisory Role - Genentech; Grail; InDi; Nucleix; Oncimmune
Research Funding - InDi (Inst); Metabolomx (Inst); Veracyte (Inst)
 
James Stevenson
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
 
Nathan A. Pennell
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly; Regeneron
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech (Inst); Merck; Newlink Genetics (Inst); Pfizer (Inst)
 
Adrian V Hernandez
No Relationships to Disclose
 
Vamsidhar Velcheti
Honoraria - Bristol-Myers Squibb; Foundation Medicine; Genentech/Roche; Merck; Novartis
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Clovis Oncology; Foundation Medicine; Genentech; Genoptix; Merck
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Eisai